海外の治験の状況「1」での検索結果
11240件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Collagenase and Needle Aponeurotomy: Single Modality Versus Combination Treatment for Dupuytren's Disease
- Dupuytren Contracture
- Canada
- 2013-01-17
Not recruiting
- Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
- Venous Thromboembolism;Venous Thromboembolism;Venous Thromboembolism;Venous Thromboembolism
- Austria, Belgium, Canada, Czech Republic, France, Hungary, Italy, Latvia, Lithuania, Netherlands, Norway, Russian Federation, Slovakia, Spain, Switzerland, Thailand, Ukraine
- 2010-03-08
Not recruiting
- A Phase 1 Study of MEDI0562 in Adult Subjects With Selected Advanced Solid Tumors
- Advanced Solid Tumors
- Korea, Republic of, United States
- 2014-12-03
Recruiting
- A Phase 1 Study to Investigate the Safety and Tolerability of REGN1979 in Patients With CD20+ B-Cell Malignancies
- Non-Hodgkin's Lymphoma;Chronic Lymphocytic Leukemia
- Germany, United States
- 2014-11-07
Not recruiting
- Phase 1, Multiple Ascending Dose Study of Anti-HER2 FCAB FS102 in HER2 Positive Solid Tumors (Anti HER2 Fcab)
- Solid Tumors That Overexpress HER2 (HER2 Positive);Solid Tumors That Overexpress HER2 (HER2 Positive);Solid Tumors That Overexpress HER2 (HER2 Positive);Solid Tumors That Overexpress HER2 (HER2 Positive)
- Canada, United States
- 2014-10-31
Not recruiting
- Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
- Herpes Simplex Infections;Herpes Simplex Infections;Herpes Simplex Infections;Herpes Simplex Infections
- United States
- 2014-10-16
Not recruiting
- A Phase 1 Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis Patients
- Primary Progressive Multiple Sclerosis;Secondary Progressive Multiple Sclerosis;Primary Progressive Multiple Sclerosis;Secondary Progressive Multiple Sclerosis;Primary Progressive Multiple Sclerosis;Secondary Progressive Multiple Sclerosis;Primary Progressive Multiple Sclerosis;Secondary Progressive Multiple Sclerosis
- United States
- 2014-09-29
Recruiting
- Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension
- Hypertension;Hypertension, Essential
- United States
- 2014-09-17
Not recruiting
- Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy Adults
- MEDI3902 for Prevention of P. Aeruginosa Pneumonia
- United States
- 2014-09-16
Not recruiting
- A Phase 1 Study Evaluating CB-5083 in Subjects With Advanced Solid Tumors
- Advanced Solid Tumors
- United States
- 2014-09-15
Not recruiting
- Phase 1, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors
- Advanced Solid Tumors;Advanced Solid Tumors
- United States
- 2014-08-22
Not recruiting
- A Phase 1 Study to Evaluate MEDI6383 Alone and in Combination With MEDI4736 in Adult Subjects With Select Advanced Solid Tumors
- Recurrent or Metastatic Solid Tumors
- Australia, United States
- 2014-08-19
Not recruiting
- A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies
- Lymphoid Hematological Malignancies;Relapsed and Refractory Multiple Myeloma
- Canada, United States
- 2014-08-15
Recruiting
- Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer
- Advanced Cancer
- Korea, Republic of, United States
- 2014-08-14
Not recruiting
- Phase 1 Trial of Hu5F9-G4, a CD47-targeting Antibody
- Solid Tumor
- United States
- 2014-08-12
Recruiting
- Testing Tissue Sodium Stores in CAPD Patients—Aims 1 & 2
- End Stage Renal Disease
- United States
- 2014-08-06
Not recruiting
- Residual Extensor Lag Approximately 1 Month After Splint or Cast Immobilization of a Mallet Finger
- Patients Present With Mallet Finger
- United States
- 2014-08-05
Not recruiting
- Rotator Cuff Repair Using Standard Double Row Technique With Platelet Rich Fibrin Membrane vs. Standard Double Row Technique
- Rotator Cuff Tear;Rotator Cuff Tear;Rotator Cuff Tear;Rotator Cuff Tear
- United States
- 2014-08-04
Not recruiting
- A Phase 1, Open-Label, Single-Dose, Pharmacokinetic and Safety Study of E7080 (24 mg) Administered to Subjects With Mild, Moderate, and Severe Renal Impairment and to Healthy Subjects
- Renal Impairment;Disease Severity
- United States
- 2014-07-22
Not recruiting
- TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM
- Glioblastoma Multiforme (GBM)
- United States
- 2014-07-15